MARKET

PML

PML

Pimco Municipal Income Ii
NYSE
9.53
-0.01
-0.10%
After Hours: 9.53 0 0.00% 16:02 09/30 EDT
OPEN
9.58
PREV CLOSE
9.54
HIGH
9.61
LOW
9.49
VOLUME
178.60K
TURNOVER
0
52 WEEK HIGH
15.03
52 WEEK LOW
9.49
TOTAL ASSET
537.06M
YTD YIELD
-27.01%
1D
5D
1M
3M
1Y
5Y
PIMCO Municipal Income Fund II declares $0.059 dividend
PIMCO Municipal Income Fund II (NYSE:PML) declares <a href...
Seekingalpha · 09/02 16:43
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below. The dis...
GlobeNewswire · 08/01 20:47
PIMCO Municipal Income Fund II goes ex-dividend tomorrow
PIMCO Municipal Income Fund II (NYSE:PML) had declared <a ...
Seekingalpha · 07/07 17:34
Tuesday Is Your Last Chance To Buy PIMCO Municipal Income Before The Dividend Payout
Tuesday marks the last chance for investors to receive the next dividend payout from PIMCO Municipal Income (NYSE:PML).
Benzinga · 05/06 14:55
Panoro Minerals Announces Receipt of Early Deposit Payment from Wheaton Precious Metals for the Cotabambas Project, Peru
Panoro Minerals Ltd. (TSXV: PML) (Lima: PML) (Frankfurt: PZM) (OTCQB: POROF) and its wholly-owned subsidiary, Panoro Trading (Cayman) Ltd. ("Panoro" or the "Company") are pleased to announce that they have received the fourteenth Early Deposit payment of U...
CNW Group · 04/04 20:00
PIMCO Municipal Income Fund II -- Moody's announces completion of a periodic review of ratings of PIMCO Municipal Income Fund II
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of PIMCO Municipal Income Fund IIGlobal Credit Research - 12 Jan 2022New York, January 12, 2022 -- Moody's Investors Service ("Moody's") has completed a periodic ...
Moody's · 01/12 20:13
UniCredit Russia Deal Would Face Skepticism, Jefferies Says
Bloomberg · 01/12 08:03
Horizon reports new analysis from late-stage Uplinza study for NMOSD in medical journal
Horizon Therapeutics (NASDAQ:HZNP) announces the publication of a post-hoc analysis from the N-MOmentum phase 2/3 trial of UPLIZNA, which highlights a sustained effect on attack risk with no new safety
Seekingalpha · 10/04/2021 13:10
More
Profile
Fund Name
Pimco Municipal Income Ii
Inception Date
2002-06-28
Benchmark
Bloomberg Municipal TR USD
Advisor Company
PIMCO
Custodian
State Street Bank and Trust Company
Manager
David Hammer